Early-TAVR Trial #2016-07
Research payments
$15,933,958
Through program year 2025, $15,933,958 in research payments was reported against Early-TAVR Trial #2016-07, across 1,815 payments, paid by Edwards Lifesciences Corporation.
- Paid by
- Edwards Lifesciences Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,129,556 | 265 |
| 2024 | Research | $1,293,643 | 312 |
| 2023 | Research | $3,753,039 | 389 |
| 2022 | Research | $1,707,765 | 174 |
| 2021 | Research | $4,049,127 | 343 |
| 2020 | Research | $4,000,827 | 332 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ythan Goldberg Bronx, NY Named on 53 payments
- Vijay Iyer Amherst, NY Named on 39 payments
- Gary Grosner Buffalo, NY Named on 27 payments
- Philippe Genereux New York, NY Named on 26 payments
- Azhil Durairaj Pasadena, CA Named on 25 payments
- Santiago Garcia Cincinnati, OH Named on 22 payments
- John Oldemeyer Fort Collins, CO Named on 18 payments
- Edwin Ho Bronx, NY Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.